You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Making the Treatment Decision

Free Monthly Informational Seminars

There are several very good options for the treatment of prostate cancer. While this is good news, some men find the decision making process overwhelming and sometimes confusing. At the PCC, we believe in a personalized approach to care where "one size doesn't fit all." Our goal is to educate you on all of your treatment options and help you weigh the pros and cons of each to make the best treatment decision for YOU.

Our free informational seminar will present treatment options for prostate cancer in a clear, unbiased format. Treatments that will be discussed include robotic surgery, HDR (high dose rate) Brachytherapy, external beam radiation therapy, active surveillance (also called watchful waiting or expectant therapy), as well as HIFU, Proton therapy and and NanoKnife therapy. This session will arm you with the information you need to effectively weigh your options by allowing you to compare cure rates, short and long term side effects, modes of treatment delivery and recovery time.

                                        4th Wednesday of the month, 7:00 pm - 8:30 pm

September 28, 2011 

RESCHEDULED:  September 28, 2011 Informational Seminar was cancelled and has been rescheduled for Thursday, October 6 from 6:00-7:30 pm

October 26, 2011

November 16, 2011  *Third Wed due to the Thanksgiving holiday

We regret that this Informational Seminar will not meet in December or January.

 

Spouses/adult family members are welcome to attend.

Bring your questions. A physician will answer questions during the final 30 minutes of the session.

 

Program is held in the Florence Hays Erb Clinical Specialty Center at Saint Joseph's (in the first floor conference room). 

Saint Joseph's Hospital is located at 5665 Peachtree Dunwoody Road, NE Atlanta, GA  30342. Please call (678) 843-7001 (select option 3) for driving directions. In addition, the hospital is adjacent to the Medical Center Marta station.

Please RSVP to Renee Sevy-Hasterok, Patient Navigator, at (678) 843-5665 or rsevy@sjha.org if  you plan to attend so we know to expect you. You will be given instructions for free parking with your RSVP.

Peer Support >>  If you are interested in speaking with other men who have undergone treatment for prostate cancer, consider attending our monthly prostate cancer support group (held on the first Wednesday of every month at 7:00 pm). This is a free group and open to those regardless of physician or hospital affiliation. Spouses and adult family members are welcome to attend. Our patient navigator can also connect you indivudually if you prefer to speak one-on-one instead of in a group setting.

 

Understanding Your Prostate Pathology Report

Harvard Medical School - Prostate Knowledge offers an excellent article on Understanding Your Prostate Pathology Report.

 

 

 

Online Decision Tools including Prostate Nomogram and Partin Tables

The American Cancer Society offers detailed information about prostate cancer diagnosis and treatment.  Treatment decision tools, like the NexProfiler Treatment Option Tool, can help you make an informed decision about your treatment. Using this tool, you can access the detailed analysis of your specific condition, uncover a statistical breakdown of treatment types, and pinpoint the exact topics you should discuss with your doctor. The Cancer Profiler Tool for Prostate Cancer provides: Full disclosure of treatment options, side effects, and outcomes; personalized reports with pros and cons of treatment; questions to ask your physician; and access to relevant abstracts of medical studies. Learn More >> The Cancer Profiler Tool for Prostate Cancer

 

Memorial Sloan-Kettering Cancer Center’s prostate nomogram is designed to help physicians and patients decide which treatment approaches will result in the greatest benefit. It is recommended that patients using the tool consult with a physician or other professional healthcare provider prior to making any treatment decisions. Learn More>> Prostate Cancer: A Conversation about PSA Screening, Active Surveillance, and Treatment Options  

 

Partin Tables, developed at the Brady Urological Institute at Johns Hopkins in 1993 by urologists Alan Partin and Patrick Walsh, can help you and your doctor to predict the chance of organ confined prostate cancer. Based upon PSA, Gleason Score, and Clinical Staging, a probability is calculated for each of the following four: Organ Confined Disease, Extraprostatic Extension, Seminal Vesicle Invasion, and Lymph Node Invasion. Your number gives you a rough idea of how many chances out of a hundred a patient with your PSA level, Gleason score and clinical stage has for each of the four criteria. Learn More>> Link to Partin Tables.

 

The Prostate Cancer Research Institute (PCRI) provides information as a free, educational resource to help patients understand their options to facilitate communication with their doctors and hopefully improve their outcomes. PCRI offers a Decision Aide which is intended to help men locate and utilize information that is pertinent to their situation. Information referenced is provided by PCRI and other sources to empower you to take charge of your treatment plan.  PCRI Papers are available on the following topics:

Learn More>> Prostate Cancer Research Institute (PCRI); Online Video Library; Extensive Prostate Cancer Resource Page

 

Disclaimer: All links to other Web sites are provided solely as a convenience to our patients. If you use these links, you will leave the Prostate Cancer Center at Saint Joseph's (PCC) Web site. The PCC is not responsible for any content, materials or other information located on or accessible from any linked site. PCC does not endorse, guarantee, or make any representation or warranties regarding any linked site, or any content, materials or other information location on or accessible from such linked site, or the results you may obtain from using such linked site. If you decide to access any linked site, you do so entirely at your own risk. You should review the policies and terms of use associated with any linked site closely before using or submitting information to the linked site.

Last Updated: December 13, 2011 (RSH)